Ning Xu

3.1k total citations
97 papers, 2.6k citations indexed

About

Ning Xu is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Ning Xu has authored 97 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 32 papers in Surgery and 22 papers in Immunology. Recurrent topics in Ning Xu's work include Sphingolipid Metabolism and Signaling (24 papers), Cholesterol and Lipid Metabolism (13 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Ning Xu is often cited by papers focused on Sphingolipid Metabolism and Signaling (24 papers), Cholesterol and Lipid Metabolism (13 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Ning Xu collaborates with scholars based in Sweden, China and Taiwan. Ning Xu's co-authors include Peter Nilsson‐Ehle, Jingting Jiang, Björn Dahlbäck, Guanghua Luo, Xiaoying Zhang, Changping Wu, Yibei Zhu, Xueguang Zhang, Jiemin Zhao and Lu Zheng and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ning Xu

94 papers receiving 2.6k citations

Peers

Ning Xu
Comparison fields: 5 of 101
  • Molecular Biology 1.0k
  • Surgery 809
  • Oncology 700
  • Immunology 643
  • Cancer Research 358
Replace Amy Simon with:
Amy Simon United States
Laurent O. Martinez France
Maaike Kockx Australia
Osama N. El‐Assal United States
Seongah Han United States
Mollie Ranalletta United States
Vincent Braunersreuther Switzerland
Jonathan C. Choy Canada
Chongren Tang United States
Amy Simon United States View profile →
Citations per field, relative to Ning Xu
Ning Xu · 1×
Citations per year, relative to Ning Xu
Ning Xu · 1×

Countries citing papers authored by Ning Xu

Since Specialization
Citations

This map shows the geographic impact of Ning Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Xu more than expected).

Fields of papers citing papers by Ning Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Xu. The network helps show where Ning Xu may publish in the future.

Co-authorship network of co-authors of Ning Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Xu. A scholar is included among the top collaborators of Ning Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Xu. Ning Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 6
2 10
3 1
4
Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling
1
5 5
6 27
7 7
8 5
9 7
10 14
11 18
12 39
13 30
14 156
15 5
16 39
17 4
18 24
19 9
20 6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026